Misconceptions regarding the association between Herbalife products and liver-related case reports in Spain

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 3, 2012, Pages 333-334

  Appelhans, Kristy ^a   Frankos, Vasilios ^b   Shao, Andrew ^c  

^a Product Compliance and Safety Herbalife International of America Inc   (United States)

^b Global Product Science and Safety and Compliance Herbalife International of America Inc   (United States)

^c Global Product Science and Safety Herbalife International of America Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBALIFE; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

BACILLUS SUBTILIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG CONTAMINATION; DRUG INFORMATION; DRUG LEGISLATION; DRUG SAFETY; HUMAN; LETTER; LIVER INJURY; LIVER TOXICITY; PRIORITY JOURNAL; SPAIN; THERAPEUTIC MISCONCEPTION;

DIETARY SUPPLEMENTS; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; PHARMACOVIGILANCE;

EID: 84858255627     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3203     Document Type: Letter

References (12)

1. Manso G, Lopez-Rivas L, Salguiero EM, Duque JM, Jimeno FJ, Andrade RJ, Lucena MI. Continuous reporting of new cases in Spain supports the relationship between Herbalife products and liver injury. Pharmacoepidemiol Drug Saf 2011. DOI: 10.1002/pds.2180.
2. The Spanish Agency for Drugs and Sanitary Products (AEMPS), Spanish Food and Nutrition Safety Agency (AESAN). [October 2011].
3. The use of the WHO-UMC system for standardized case causality assessment. [October 2011].
4. Spanish DILI Registry. Karch and Lasagna algorithm. [October 2011].
5. Ignarro L, Heber D, Henig YS. Herbalife nutritional products and liver injury revisited. J Hepatol 2008. DOI: 10.1016/j.jhep.2008.05.005.
6. Appelhans K, Goldstein L. Revisiting liver injury associated with dietary supplements. Liver Int 2011. DOI: 10.1111/j.1478-3231.2011.02547.x.
7. Stickel F. Slimming at all costs: Herbalife-induced liver injury. J Hepatol 2007; 47: 521-526.
8. Stickel F, Kessebohm K, Weimann R, Seitz HK. Review of liver injury associated with dietary supplements. Liver Int 2011; 31: 595-605.
9. Appelhans K, Frankos V. Herbal medicine hepatotoxicity revisited. J Hepatol 2011. DOI: 10.1016/j.jhep.2011.06.019.
10. Bejar E, Smith CR, Appelhans K, Henig YS. Correcting a misrepresentation of hypervitaminosis A attributed to Herbalife product consumption. Exp Mol Pathol 2011; 90(3): 320-321.
11. Stickel F, Droz S, Patsenker E, Bögli-Stuber K, Aebi B, Leib SL. Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J Hepatol 2009; 50: 111-117.
12. Biotechnology Program Under the Toxic Substances Control Act (TSCA). Bacillus subtilis final risk assessment. [February 1997].